Dna Group (T.R.) Statistics

Total Valuation

TLV:DNA has a market cap or net worth of ILS 119.84 million. The enterprise value is 51.53 million.

Market Cap	119.84M
Enterprise Value	51.53M

Important Dates

The last earnings date was Wednesday, March 26, 2025.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TLV:DNA has 123.16 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	123.16M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	51.56%
Owned by Institutions (%)	0.18%
Float	59.66M

Valuation Ratios

The trailing PE ratio is 5.44.

PE Ratio	5.44
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.18
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2.33
EV / Sales	168.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 60.77

Current Ratio	60.77
Quick Ratio	60.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.46% and return on invested capital (ROIC) is -1.04%.

Return on Equity (ROE)	24.46%
Return on Assets (ROA)	-1.02%
Return on Invested Capital (ROIC)	-1.04%
Return on Capital Employed (ROCE)	-1.46%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.78% in the last 52 weeks. The beta is 0.15, so TLV:DNA's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+24.78%
50-Day Moving Average	105.80
200-Day Moving Average	88.36
Relative Strength Index (RSI)	36.40
Average Volume (20 Days)	104,889

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:DNA had revenue of ILS 306,000 and earned 22.10 million in profits. Earnings per share was 0.18.

Revenue	306,000
Gross Profit	306,000
Operating Income	-1.51M
Pretax Income	23.40M
Net Income	22.10M
EBITDA	n/a
EBIT	-1.51M
Earnings Per Share (EPS)	0.18

Full Income Statement

Balance Sheet

The company has 68.31 million in cash and n/a in debt, giving a net cash position of 68.31 million or 0.55 per share.

Cash & Cash Equivalents	68.31M
Total Debt	n/a
Net Cash	68.31M
Net Cash Per Share	0.55
Equity (Book Value)	101.47M
Book Value Per Share	0.82
Working Capital	67.30M

Full Balance Sheet

Cash Flow

Operating Cash Flow	1.61M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -493.46% and 7,220.92%.

Gross Margin	100.00%
Operating Margin	-493.46%
Pretax Margin	7,648.04%
Profit Margin	7,220.92%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:DNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	18.44%
FCF Yield	n/a

Stock Splits

The last stock split was on November 10, 2019. It was a reverse split with a ratio of 0.1666666667.

Last Split Date	Nov 10, 2019
Split Type	Reverse
Split Ratio	0.1666666667

Scores

TLV:DNA has an Altman Z-Score of 20.88.

Altman Z-Score	20.88
Piotroski F-Score	n/a